Başlık için Tıp Fakültesi listeleme
Toplam kayıt 4903, listelenen: 2871-2890
-
Long-term comparison of everolimus- vs. novolimus-eluting bioresorbable vascular scaffolds
(Elsevier Science Inc, 2020)BACKGROUND The vast majority of clinical trials regarding bioresorbable vascular scaffold (BVS) use came from comparison of everolimus-eluting scaffolds with metallic stents, and it remains unclearwhether similar results ... -
Long-term comparison of everolimus- vs. novolimus-eluting bioresorbable vascular scaffolds in real world patients
(Termedia Publishing House Ltd., 2020)Introduction: Elevated risk of adverse events in comparison to metallic stents resulted in withdrawal of everolimus-eluting bioresorbable scaffolds (eBVS), known as the most intensively studied BVS. There is a paucity of ... -
Long-term course of COVID-19 vaccination-related headache: A prospective multicenter follow-up study
(SAGE Publications Ltd, 2023)... -
Long-term effects of vagus nerve stimulation in refractory pediatric epilepsy: A single-center experience
(Academic Press Inc Elsevier Science, 2020)Introduction: Vagus nerve stimulation (VNS) has been used as an adjunctive therapy for both children and adults with refractory epilepsy, over the last two decades. In this study, we aimed to evaluate the long-term effects ... -
Long-term efficacy of different doses of steroid in hospitalized COVID-19 patients: A prospective cohort study
(European Publishing, 2023)INTRODUCTION The aim of our study was to investigate the long-term effects of different doses of steroid therapy given in the acute period in hospitalized coronavirus disease 2019 (COVID-19) patients. METHODS A total of ... -
Long-term outcome and safety in patients treated with immune checkpoint blockade therapies for urothelial carcinoma: Experience from real-world clinical practice
(Lippincott Williams & Wilkins, 2022)Background: Anti-tumor activity and manageable safety profile of immune checkpoint blockade therapies (ICT) have been demonstrated in previous clinical trials in patients with metastatic urothelial carcinoma. To the best ... -
Long-term outcomes of absorb bioresorbable vascular scaffold using predilation, sizing, and postdilation protocol in a real-world patient population
(NLM (Medline), 2021)OBJECTIVE: Bioresorbable vascular scaffolds (BVSs) have been a disappointment in the evolution of drug-eluting stents used in percutaneous coronary intervention because an excessive number of thrombotic complications have ... -
Long-term outcomes of patients presenting with acute coronary syndrome and implanted with bioresorbable scaffold
(Yuzuncu Yıl University Faculty of Medicine, 2022)A bioresorbable scaffold (BRS) has been used in the latest stages of stent technology and is a less-known material than drug-eluting stents (DES). In this study, we aimed to evaluate the long-term clinical outcomes of BRS ... -
Long-term prognosis of patients with heart failure: Follow-up results of journey HF-TR study population
(Turkish Society of Cardiology, 2023)Background: Despite advances in therapeutic management of patients with heart failure, there is still an increasing morbidity and mortality all over the world. In this study, we aimed to present the 3-year follow-up outcomes ... -
Long-term radiological outcomes of short-segment stabilization in thoracic burst fracture
(Haydarpasa Numune Training and Research Hospital, 2022)Introduction: Short-segment (SS) transpedicular instrumentation and distraction have been used as a popular method recently due to the kyphotic angulation and adequate spinal canal decompression provided by the fusion of ... -
Long-term results of long segment coronary artery lesions overlapped with novolimus-eluting DESolve scaffold: Disappointment or futuristic?
(Turkish Society of Cardiology, 2021)Objective: The data on using novolimus-eluting DESolve bioresorbable scaffolds (BVS) for long-segment coronary artery lesions remains insufficient. In this study, our main objective was to assess the long-term effects of ... -
Long-term results of microfracture in the treatment of talus osteochondral lesions
(Springer, 2016)Osteochondral lesions of the talus are common injuries, and many clinicians consider arthroscopic debridement and microfracture as the first-stage treatment. This study assessed the long-term clinical and radiographic ... -
Long-Term results of mini-open repair technique in the treatment of acute achilles tendon rupture: A prospective study
(Elsevier Science Inc, 2016)An ideal surgical treatment of acute Achilles tendon rupture includes restoring the original length of the tendon, minimizing possible adhesions with the surrounding tissues, minimizing the risk of repeat rupture, alleviating ... -
Long-term results of sterile corneal allograft ring segments implantation in keratoconus treatment
(2024)Purpose: To evaluate the efficacy and safety of sterile corneal allograft ring segments implantation for the treatment of keratoconus by analyzing long-term visual, refractive, and tomographic clinical outcomes. Methods: ... -
Long-termoutcomes following cryoablation of atrioventricular nodal reentrant tachycardia in children
(Wiley, 2018)BackgroundAtrioventricular nodal reentrant tachycardia (AVNRT) is a common tachyarrhythmia substrate inchildren, which is successfully treated by catheter ablation using radiofrequency or cryothermal energy. In recent ... -
Longitudinal assessment of intraocular pressure in premature infants
(SAGE Publications Ltd, 2018)Purpose: To investigate the longitudinal change in intraocular pressure (IOP) in premature infants and to establish a normative IOP value. Methods: Forty premature infants with a gestational age (GA) of 26 weeks were ... -
Longitudinal assessment of meibomian glands and tear film layer in systemic isotretinoin treatment
(SAGE Publications Ltd, 2022)Purpose: This study aimed to analyze the changes in meibomian glands (MGs) and tear film layer over time in patients taking systemic isotretinoin treatment. Methods: Patients who received systemic isotretinoin treatment ... -
Lorlatinib in ALK- or ROS1-positive non-small cell lung cancer patients: Experience from an early access program in Turkey
(Elsevier Science, 2019)Background: Lorlatinib, a third generation ALK and ROS1 inhibitor, is indicated for the treatment of patients with ALK+ metastatic NSCLC whose disease has progressed on crizotinib and at least one second-generation ALK ...
